We are live on ! Find out more
EPM

Equitec Proprietary Markets Portfolio holdings

AUM $187M
1-Year Est. Return 179.87%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+179.87%
3 Year Est. Return
+470.49%
5 Year Est. Return
+544.99%
10 Year Est. Return
AUM
$1.65B
AUM Growth
-$844M
Cap. Flow
-$935M
Cap. Flow %
-56.72%
Top 10 Hldgs %
88.64%
Holding
157
New
30
Increased
27
Reduced
32
Closed
67

Sector Composition

1 Healthcare 1.4%
2 Consumer Staples 1.18%
3 Materials 0.75%
4 Technology 0.72%
5 Financials 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$788M 47.8%
3,343,300
-714,700
-18% -$166M
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$505M 30.62%
2,141,300
-2,753,900
-56% -$640M
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$57.9M 3.51%
245,800
-32,605
-12% -$7.58M
MJN
4
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
$27.4M 1.66%
+307,100
New +$25.3M
MON
5
PUT
DELISTED
Monsanto Co
MON
$19.5M 1.18%
172,500
+16,500
+11% +$1.83M
NXPI icon
6
PUT
NXP Semiconductors
NXPI
$67.3B
$14.4M 0.88%
139,400
+13,200
+10% +$1.33M
MJN
7
DELISTED
Mead Johnson Nutrition Company
MJN
$13M 0.79%
+145,648
New +$12M
MJN
8
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
$12.6M 0.76%
+141,300
New +$11.6M
HUM icon
9
CALL
Humana
HUM
$48B
$12.5M 0.76%
60,800
+31,400
+107% +$6.49M
HUM icon
10
PUT
Humana
HUM
$48B
$11.1M 0.68%
54,000
+52,000
+2,600% +$10.8M
HUM icon
11
Humana
HUM
$48B
$10.7M 0.65%
51,860
+45,360
+698% +$9.38M
NXPI icon
12
NXP Semiconductors
NXPI
$67.3B
$9.77M 0.59%
94,400
+8,500
+10% +$859K
ESPR
13
PUT
DELISTED
Esperion Therapeutics
ESPR
$9.34M 0.57%
+264,400
New +$6.05M
RAD
14
PUT
DELISTED
Rite Aid Corporation
RAD
$9.01M 0.55%
106,045
-2,760
-3% -$332K
MON
15
DELISTED
Monsanto Co
MON
$8.72M 0.53%
77,000
-2,900
-4% -$321K
WDC icon
16
PUT
Western Digital
WDC
$164B
$8.7M 0.53%
139,444
-79,777
-36% -$4.58M
MON
17
CALL
DELISTED
Monsanto Co
MON
$8.38M 0.51%
74,000
+30,700
+71% +$3.4M
WWAV
18
PUT
DELISTED
The WhiteWave Foods Company
WWAV
$7.25M 0.44%
+129,100
New +$7.12M
RAD
19
CALL
DELISTED
Rite Aid Corporation
RAD
$7.14M 0.43%
83,975
-13,825
-14% -$1.66M
RAD
20
DELISTED
Rite Aid Corporation
RAD
$6.79M 0.41%
79,830
+53,740
+206% +$6.47M
WWAV
21
DELISTED
The WhiteWave Foods Company
WWAV
$6.47M 0.39%
+115,300
New +$6.36M
CI icon
22
CALL
Cigna
CI
$74.5B
$6.3M 0.38%
43,000
-2,000
-4% -$295K
CAB
23
PUT
DELISTED
Cabela's Inc
CAB
$6.11M 0.37%
115,000
-56,800
-33% -$2.91M
CAB
24
DELISTED
Cabela's Inc
CAB
$5.79M 0.35%
109,104
-76,600
-41% -$3.93M
SYT
25
PUT
DELISTED
Syngenta Ag
SYT
$5.44M 0.33%
+61,500
New +$5.27M

Similar funds

Equitec Proprietary Markets's Q1 2017 Portfolio in Review

As of Q1 2017, Equitec Proprietary Markets held 157 positions worth $1.65B, down 34% from $2.49B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Equitec Proprietary Markets withdrew a net $935M in Q1 2017, closing 67 positions and reducing 32 holdings. Its most notable exit was Harman International Industries, an estimated $6.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.4% of assets, up from 0.89% a quarter earlier, followed by Consumer Staples and Materials.

Against the trend, Equitec Proprietary Markets opened a new position in Mead Johnson Nutrition Company worth $13M.

  • Equitec Proprietary Markets's largest Q1 2017 buy was Mead Johnson Nutrition Company: 145,648 shares worth $13M.
  • Equitec Proprietary Markets added most to Humana in Q1 2017, an estimated $9.38M increase.
  • Equitec Proprietary Markets's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.58M.
  • Equitec Proprietary Markets fully exited Harman International Industries in Q1 2017, selling an estimated $6.17M.
  • Equitec Proprietary Markets's ten largest holdings make up 89% of its $1.65B portfolio in Q1 2017.
  • Equitec Proprietary Markets opened 30 new positions and closed 67 in Q1 2017.
  • Equitec Proprietary Markets's portfolio value fell 34% quarter-over-quarter to $1.65B.

Based on Equitec Proprietary Markets's 13F filing for Q1 2017, filed 24 Apr 2017.